Christopher P. Day
Impact in
- Hepatology top 0.05%
- Liver Disease and Transplantation
- Liver Diseases and Immunity
- Epidemiology top 0.01%
- Liver Disease Diagnosis and Treatment
Papers in
- Epidemiology 105
- Liver Disease Diagnosis and Treatment 100
-
- Alcohol Consumption and Health Effects 36
- Co-authors
- Quentin M. Anstee (32 shared papers)Giovanni Targher (7 shared papers)Alastair D. Burt (28 shared papers)Ann K. Daly (36 shared papers)Guruprasad P. Aithal (18 shared papers)Oliver James (14 shared papers)Enzo Bonora (1 shared paper)Anna Mae Diehl (2 shared papers)
- Journals
- Journal of Hepatology (26 papers)Hepatology (20 papers)Gut (14 papers)Gastroenterology (11 papers)Seminars in Liver Disease (5 papers)
- Partner nations
- United KingdomItalyUnited States
In The Last Decade
Christopher P. Day
185 papers receiving 30.6k citations
Christopher P. Day's Hit Papers
Peers
Comparison fields: 5 of 149
- Hepatology 6.1k
- Epidemiology 19.9k
- Endocrinology, Diabetes and Metabolism 6.9k
- Pharmacology 2.6k
- Pathology and Forensic Medicine 3.8k
Countries citing papers authored by Christopher P. Day
This map shows the geographic impact of Christopher P. Day's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher P. Day with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher P. Day more than expected).
Fields of papers citing papers by Christopher P. Day
This network shows the impact of papers produced by Christopher P. Day. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher P. Day. The network helps show where Christopher P. Day may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher P. Day, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 186 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The NAFLD fibrosis score Hit paper breakdown → | 2007 | 2395 |
| 2 | Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease Hit paper breakdown → | 2010 | 1552 |
| 3 | Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis Hit paper breakdown → | 2013 | 1368 |
| 4 | QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Hit paper breakdown → | 1990 | 960 |
| 5 | Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications Hit paper breakdown → | 1999 | 950 |
| 6 | Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis Hit paper breakdown → | 2017 | 932 |
| 7 | Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management Hit paper breakdown → | 2014 | 807 |
| 8 | Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients Hit paper breakdown → | 2007 | 784 |
| 9 | HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin Hit paper breakdown → | 2009 | 737 |
| 10 | The natural history of nonalcoholic fatty liver: A follow-up study Hit paper breakdown → | 1995 | 732 |
| 11 | Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease Hit paper breakdown → | 2010 | 693 |
| 12 | Nonalcoholic fatty liver disease Hit paper breakdown → | 2015 | 640 |
| 13 | Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis Hit paper breakdown → | 2016 | 606 |
| 14 | Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers Hit paper breakdown → | 2007 | 582 |
| 15 | Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease† Hit paper breakdown → | 2010 | 498 |
| 16 | Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum Hit paper breakdown → | 2016 | 477 |
| 17 | Non-alcoholic fatty liver disease: The mist gradually clears Hit paper breakdown → | 2008 | 465 |
| 18 | TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease Hit paper breakdown → | 2014 | 462 |
| 19 | Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review Hit paper breakdown → | 2011 | 429 |
| 20 | Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss Hit paper breakdown → | 2011 | 408 |
About Christopher P. Day
Christopher P. Day is a scholar working on Epidemiology, Pathology and Forensic Medicine, Endocrinology, Diabetes and Metabolism, Hepatology and Pharmacology, having authored 186 papers that have together received 31.4k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (100 papers), Alcohol Consumption and Health Effects (36 papers), Diet, Metabolism, and Disease (34 papers), Drug-Induced Hepatotoxicity and Protection (15 papers), Liver Disease and Transplantation (13 papers), Lipid metabolism and disorders (9 papers), Endoplasmic Reticulum Stress and Disease (9 papers) and Hepatitis C virus research (8 papers). The work is most often cited by research in Hepatology (6.1k citations), Epidemiology (19.9k citations), Endocrinology, Diabetes and Metabolism (6.9k citations), Pharmacology (2.6k citations) and Pathology and Forensic Medicine (3.8k citations). Christopher P. Day has collaborated with scholars based in United Kingdom, Italy and United States. Frequent co-authors include Quentin M. Anstee, Giovanni Targher, Alastair D. Burt, Ann K. Daly, Guruprasad P. Aithal, Oliver James, Enzo Bonora, Anna Mae Diehl, R. W. F. Campbell and Stuart McPherson. Their work appears in journals such as Journal of Hepatology, Hepatology, Gut, Gastroenterology and Seminars in Liver Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.